长期家庭氧疗对老年慢性阻塞性肺疾病稳定期多因素分级系统指数的影响
发布时间：2019-03-30 18:35
【摘要】：正老年慢性阻塞性肺疾病(COPD)患者肺功能差,恶化快〔1,2〕。依据COPD诊治指南〔2〕对于Ⅳ期COPD稳定期患者在吸入长效β2受体激动剂(LABA)+吸入性糖皮质激素(ICS)+长效抗胆碱能药物(LAMA)及其他药物治疗基础上可加用长期家庭氧疗(LTOT)。以往COPD患者病情严重程度及生活质量的评价多依靠第1秒用力呼气量(FEV1%)pred,而Celli等〔3〕提出的多因素分级系统(BODE)分级方法综合了体重指数(BMI)(B)、气道阻塞程度(O)、呼吸困难分级(D)和运动耐力(E)4种参数,可以较全面评估患者的病情与生活质量。目前
[Abstract]:Elderly patients with chronic obstructive pulmonary disease (COPD) suffered from poor pulmonary function and rapid deterioration (1, 2). According to COPD's guidelines for diagnosis and treatment (2) on the basis of inhaling long-acting 尾 2 receptor agonist (LABA) inhaled glucocorticoid (ICS) long-acting anti-cholinergic drug (LAMA) and other drugs in patients with stage 鈪，
本文编号：2450367
[Abstract]:Elderly patients with chronic obstructive pulmonary disease (COPD) suffered from poor pulmonary function and rapid deterioration (1, 2). According to COPD's guidelines for diagnosis and treatment (2) on the basis of inhaling long-acting 尾 2 receptor agonist (LABA) inhaled glucocorticoid (ICS) long-acting anti-cholinergic drug (LAMA) and other drugs in patients with stage 鈪，
本文编号：2450367
本文链接：https://www.wllwen.com/yixuelunwen/huxijib/2450367.html
最近更新
教材专著
